PATENT CLAIM ANALYSIS

Application Number: 16055386
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["546", "122000"]

Abstract:
The invention provides compounds of formula (I): wherein the variables are defined in the specification, or a pharmaceutically-acceptable salt thereof, that are inhibitors of JAK kinases. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat inflammatory bowel diseases, and processes and intermediates useful for preparing such compounds.

Claim (Index 31):
The crystalline solvate of  claim 30  wherein the powder X-ray diffraction pattern is further characterized by having one additional diffraction peak at a 2\u03b8 value of 21.20\u00b10.20.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 96.0
- Lexical Diversity: 1.36957
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15631220', '16014233', '15165126', '15498803', '16050227']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.784759485185686
- 35 USC 102 Novelty (BERT): 0.5677946175940359
- Combined Prediction Score: 0.763062998426521
- Mean Citation Score: 358.032708
- Max Citation Score: 442.3371
- Similarity Product: 390.2460318541288

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test